DR. DAVID W GREENWALD MD NPI 1558380295

NPI Details

DR. David W Greenwald, MD is a hematology and oncology internal medicine in Kingston, PA with 56 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. David W Greenwald, MD NPI is 1558380295. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1970

The provider's business location address is:

382 PIERCE ST
KINGSTON, PA
ZIP 18704-535
Phone: (570) 288-7231

The NPI 1558380295 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, atezolizumab, 10 mg (HCPCS:J9022)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Bilirubin level, direct (HCPCS:82248)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Magnesium level (HCPCS:83735)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Unclassified drugs (HCPCS:J3490)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection, mannitol, 25% in 50 ml (HCPCS:J2150)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• 5% dextrose/water (500 ml = 1 unit) (HCPCS:J7060)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Blood creatinine level (HCPCS:82565)
• Urinalysis, manual test (HCPCS:81002)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Stool analysis for blood, by peroxidase activity (HCPCS:82272)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Uric acid level, blood (HCPCS:84550)

The enumeration date for this NPI number is 7/19/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.